Aktis Oncology, Inc (AKTS) insider trading
Every open-market stock purchase and sale by Aktis Oncology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $114M over the last 12 months (6 buys).
- Last insider buy: EcoR1 Capital LLC (Director), $37.4M, 9 months ago.
Last 12 months: insiders bought $114M (6 buys) and sold $0 (0 sales). Last close $18.98 on Jun 9, 2026.
Recent AKTS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Apr 15, 2026 | Glenn Gormley (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | EcoR1 Capital LLC (Director) | Bought | $37.4M |
| Jan 12, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Bought | $20M |
| Jan 12, 2026 | Ansbert Gadicke (Insider) | Bought | $20M |
| Jan 12, 2026 | Helen Susan Kim (Insider) | Bought | $14.6M |
| Jan 12, 2026 | Vida Ventures II LLC (Insider) | Bought | $14.6M |
| Jan 12, 2026 | Todd Foley (Insider) | Bought | $4.2M |
| Jan 12, 2026 | EcoR1 Capital LLC (Director) | Bought | $2.6M |
| Jan 12, 2026 | Vida Ventures II LLC (Insider) | Bought | $406K |
| Jan 12, 2026 | Helen Susan Kim (Insider) | Bought | $406K |
| Jan 12, 2026 | Ansbert Gadicke (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Ansbert Gadicke (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Ansbert Gadicke (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Ansbert Gadicke (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Ansbert Gadicke (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | EcoR1 Capital LLC (Director) | Bought (not open market) | — |
| Jan 12, 2026 | Todd Foley (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Ansbert Gadicke (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | EcoR1 Capital LLC (Director) | Bought (not open market) | — |
| Jan 12, 2026 | Vida Ventures II LLC (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Helen Susan Kim (Insider) | Bought (not open market) | — |
Who's trading AKTS
- Glenn Gormley, Insider: other filings, last Apr 15, 2026
- Vida Ventures II LLC, Insider: bought $15M (2 buys), last Jan 12, 2026
- EcoR1 Capital LLC, Director: bought $40M (2 buys), last Jan 12, 2026
- Todd Foley, Insider: bought $4.2M (1 buy), last Jan 12, 2026
- Ansbert Gadicke, Insider: bought $20M (1 buy), last Jan 12, 2026
- Helen Susan Kim, Insider: bought $15M (2 buys), last Jan 12, 2026
- Mpm Bioventures 2018 L.p., Insider: bought $20M (1 buy), last Jan 12, 2026
- Lloyd Mitchell Segal, Insider: other filings, last Jan 12, 2026
Get free alerts when an insider at Aktis Oncology, Inc files a new trade →